相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
Ronald P. Gladue et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
Mohamad Hussein et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
C. G. Gerestein et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma
Jeong-Won Lee et al.
CLINICAL CANCER RESEARCH (2009)
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
David M. Gershenson et al.
GYNECOLOGIC ONCOLOGY (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo
Yugang Wu et al.
CELLULAR IMMUNOLOGY (2008)
TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation
Tony J. Vanden Bush et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma
Henrik von Euler et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation
Emanuela Castigli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation
Wlodzimierz Luczynski et al.
ANNALS OF HEMATOLOGY (2007)
Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines
Bohuslav Melichar et al.
GYNECOLOGIC ONCOLOGY (2007)
Triggering CD40 on endothelial cells contributes to tumor growth
Claudia Chiodoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients
Ian D. Davis et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates
Sean K. Kelley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model
Helena Dzojic et al.
PROSTATE (2006)
Transfection of CD40 in a human oral squamous cell carcinoma keratinocyte line upregulates immune potency and costimulatory molecules
MV Dorrego et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells
C Mayr et al.
BLOOD (2005)
Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
CL Law et al.
CANCER RESEARCH (2005)
Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L
JK Lee et al.
CELLULAR IMMUNOLOGY (2005)
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: Clinical implications
YT Tai et al.
CANCER RESEARCH (2004)
Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation
M Fotin-Mleczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Upregulation of CD40 expression on endothelial cells infected with human cytomegalovirus
T Maisch et al.
JOURNAL OF VIROLOGY (2002)
The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways
L Burysek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma
TJ Jang
YONSEI MEDICAL JOURNAL (2002)
T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody
AL Tutt et al.
JOURNAL OF IMMUNOLOGY (2002)
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity
Y Morel et al.
JOURNAL OF IMMUNOLOGY (2001)
Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells
L Lefrançois et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
